V

Verastem

D
VSTM
USD
-0.265
(-6.8653%)
Market Closed
32,794.00
Volume
-2.92
EPS
-
Div Yield
-1.119938
P/E
144,676,263.28
Market Cap
Today
-6.9858%
1 Week
-4.515%
1 Month
25.919%
6 Months
-68.520%
12 Months
-49.295%
Year To Date
-55.835%
All Time
0%

Title:
Verastem

Sector:
Healthcare
Industry:
Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Do you need help or have a question?